The enchanting canvas of CAR technology: Unveiling its wonders in non-neoplastic diseases

Jinhui Shu,Wei Xie,Zhaozhao Chen, Rienk Offringa,Yu Hu,Heng Mei

Med(2024)

引用 0|浏览2
暂无评分
摘要
Chimeric antigen receptor (CAR) T cells have made a groundbreaking advancement in personalized immunotherapy and achieved widespread success in hematological malignancies. As CAR technology continues to evolve, numerous studies have unveiled its potential far beyond the realm of oncology. This review focuses on the current applications of CAR-based cellular platforms in non-neoplastic indications, such as autoimmune, infectious, fibrotic, and cellular senescence-associated diseases. Furthermore, we delve into the utilization of CARs in non-T cell populations such as natural killer (NK) cells and macrophages, highlighting their therapeutic potential in non-neoplastic conditions and offering the potential for targeted, personalized therapies to improve patient outcomes and enhanced quality of life.
更多
查看译文
关键词
CAR,autoimmune diseases,infectious diseases,fibrotic diseases,cellular senescence,CAR-NK,CAR macrophage
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要